OUTCOMES OF ULTRASOUND-MONITORED TREATMENT OF DIVELOPMENTAL DYSPLASIA OF THE HIP GRAF TYPE II
Abstract
Introduction: The management of developmental dysplasia of the hips (DDH) type Graf IIa is still controversial. This study aims to examine the outcomes of ultrasound-monitored Pavlik harness treatment, as well as the effects of associated factors, such as gender, side of DDH, the age at the treatment start, and laterality on the treatment outcomes in different Graf type II subtypes.
Methods: A cohort retrospective investigation was performed on 88 ultrasound-screened infants or 125 hips diagnosed with Graf type II dysplasia during a six-month period at a single institution, the University Clinic for Orthopedic Surgery, Skopje. Subsequently, 47 infants (18 boys, 29 girls) or 73 hips who underwent Pavlik harness treatment with at least one follow-up throughout treatment monitoring were included in this study.
Results: The treatment success rate of the right DDH Graf type IIa (-) was higher (70.8%) compared to the rate of success (50%) in the treatment of left Graf type IIa (-) hips. The mean age of the infants at the treatment start in successfully treated Graf type IIa (-) hips was lower (9.12 ±2.27 weeks) compared to the age of the infants with treatment failure at the last follow-up (11.33 ±3.06 weeks), P= 0.04.
Conclusion: The age of treatment initiation and the side of DDH were the most relevant factors related to the treatment outcome. Infants with maturational deficit hips, Graf type IIa (-), should undergo early initiated, carefully guided, and monitored Pavlik harness treatment.
References
2. Husum HC, Thomsen JL, Kold S, Maimburg RD, Rahbek O. Referral criteria recognition of screeners in the Danish screening programme for hip dysplasia. Danish Medical Journal. 2022 Jan;69(2):A01210098. PMID: 35088700.
3. Xu N, Xia B, Tao H, Sun K, Liu Q, Chen W, Wang D, Gao H, Guo Y, Liu Y, Gao J, Teng J, Li T, He Q, Wu Z. Epidemiological investigation and ultrasonic diagnosis of developmental dysplasia of the hip in Chinese infants: A large multi-center cohort study. Medicine (Baltimore). 2022 Jan 14;101(2):e28320. doi: 10.1097/MD.0000000000028320. PMID: 35029175; PMCID: PMC8758026.
4. Koob S, Garbe W, Bornemann R, Ploeger MM, Scheidt S, Gathen M, Placzek R. Is Prematurity a Protective Factor Against Developmental Dysplasia of the Hip? A Retrospective Analysis of 660 Newborns. Ultraschall Med. 2022 Apr;43(2):177-180. English. doi: 10.1055/a-1161-8984. Epub 2020 Jul 28. PMID: 32722821.
5. Aroojis A, Anne RP, Li J, et al. Surveillance for Developmental Dysplasia of the Hip in India: Consensus Guidelines From the Pediatric Orthopaedic Society of India, Indian Academy of Pediatrics, National Neonatology Forum of India, Indian Radiological and Imaging Association, Indian Federation of Ultrasound in Medicine and Biology, Federation of Obstetric and Gynaecological Societies of India, and Indian Orthopaedic Association. Indian Pediatrics. 2022 Mar:S097475591600416. PMID: 35348125.
6. Schwend RM, Shaw BA, Segal LS. Evaluation and treatment of developmental hip dysplasia in the newborn and infant. Pediatr Clin North Am. 2014;61(6):1095-1107. doi:10.1016/j.pcl.2014.08.008
7. Yu RX, Gunaseelan L, Malik AS, Arulchelvan A, Yue E, Siddiqua A, Hamid MA. Utility of Clinical and Ultrasonographic Hip Screening in Neonates for Developmental Dysplasia of the Hip. Cureus. 2021 Oct 5;13(10):e18516. doi: 10.7759/cureus.18516. PMID: 34754674; PMCID: PMC8568482.
8. Puhan MA, Woolacott N, Kleijnen J, Steurer J. Observational studies on ultrasound screening for developmental dysplasia of the hip in newborns - a systematic review. Ultraschall Med. 2003;24(6):377-382. doi:10.1055/s-2003-45213
9. Bilgili F, Sağlam Y, Göksan SB, Hürmeydan ÖM, Birişik F, Demirel M. Treatment of Graf Type IIa Hip Dysplasia: A Cut-off Value for Decision Making. Balkan Med J. 2018 Nov 15;35(6):427-430. doi: 10.4274/balkanmedj.2017.1150. Epub 2018 Jul 3. PMID: 29966996; PMCID: PMC6251377.
10. Liu B, Hu X, Li L, Gao S. Morphological Development of the Hip in Normal Infants Under Six Months of Age by the Graf Ultrasound Method. Front Pediatr. 2022 May 9;10:914545. doi: 10.3389/fped.2022.914545. PMID: 35615629; PMCID: PMC9126495.
11. Graf R. Classification of hip joint dysplasia by means of sonography. Arch Orthop Trauma Surg. 1984;102(4):248-255. doi:10.1007/BF00436138
12. Synder M, Harcke HT, Domzalski M. Role of ultrasound in the diagnosis and management of developmental dysplasia of the hip: an international perspective. Orthop Clin North Am. 2006;37(2):141-v. doi:10.1016/j.ocl.2005.11.002
13. Taylor IK, Burlile JF, O'Brien K, Schaeffer EK, Mulpuri K, Shea KG. Developmental Dysplasia of the Hip: An Examination of Care Practices of Pediatricians. J Pediatr. 2022 Feb 26:S0022-3476(22)00168-8. doi: 10.1016/j.jpeds.2022.02.047. Epub ahead of print. PMID: 35231491.
14. Omeroğlu H, Caylak R, Inan U, Köse N. Ultrasonographic Graf type IIa hip needs more consideration in newborn girls. J Child Orthop. 2013;7(2):95-98. doi:10.1007/s11832-012-0476-1
15. Kosar P, Ergun E, Gökharman FD, Turgut AT, Kosar U. Follow-up sonographic results for Graf type 2A hips: association with risk factors for developmental dysplasia of the hip and instability. J Ultrasound Med. 2011;30(5):677-683. doi:10.7863/jum.2011.30.5.677
16. Mureşan S, Mărginean MO, Voidăzan S, Vlasa I, Sîntean I. Musculoskeletal ultrasound: a useful tool for diagnosis of hip developmental dysplasia: One single-center experience. Medicine. 2019 Jan;98(2):e14081. DOI: 10.1097/md.0000000000014081. PMID: 30633215; PMCID: PMC6336624.
17. Kitoh H, Kawasumi M, Ishiguro N. Predictive factors for unsuccessful treatment of developmental dysplasia of the hip by the Pavlik harness. J Pediatr Orthop. 2009;29(6):552-557. doi:10.1097/BPO.0b013e3181b2f200
18. Atalar H, Sayli U, Yavuz OY, Uraş I, Dogruel H. Indicators of successful use of the Pavlik harness in infants with developmental dysplasia of the hip. Int Orthop. 2007;31(2):145-150. doi:10.1007/s00264-006-0097-8
19. Palocaren T, Rogers K, Haumont T, Grissom L, Thacker MM. High failure rate of the Pavlik harness in dislocated hips: is it bilaterality?. J Pediatr Orthop. 2013;33(5):530-535. doi:10.1097/BPO.0b013e318287ffc6
20. Borowski A, Thawrani D, Grissom L, Littleton AG, Thacker MM. Bilaterally dislocated hips treated with the Pavlik harness are not at a higher risk for failure. J Pediatr Orthop. 2009;29(7):661-665. doi:10.1097/BPO.0b013e3181b528f8
21. Lussier, E. , Lei, W. , Sun, Y. , Chen, H. , Chang, T. and Chang, C. Newborn Hip Screenings at 4 to 8 Weeks Are Optimal in Predicting Referral and Treatment Outcomes: A Retrospective Review. Open Journal of Pediatrics 2020; 10(02):332-346. doi: 10.4236/ojped.2020.102034.
22. Ziegler CM, Ertl KM, Delius M, Foerster KM, Crispin A, Wagner F, Heimkes B. Clinical examination and patients' history are not suitable for neonatal hip screening. J Child Orthop. 2022 Feb;16(1):19-26. doi: 10.1177/18632521221080472. Epub 2022 Apr 5. PMID: 35615397; PMCID: PMC9124910.
23. Woodacre T, Ball T, Cox P. Epidemiology of developmental dysplasia of the hip within the UK: refining the risk factors. J Child Orthop. 2016;10(6):633-642. doi:10.1007/s11832-016-0798-5
24. Dzoleva-Tolevska R, Poposka A, Georgieva D. Results of ultrasound screening of the hips in newborns and infants. Sanamed. 2012;7(2): 97–101
Copyright (c) 2022 Sanamed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal Sanamed is published under an Open Access license. All its content is available free of charge. Users can read, download, copy, distribute, print, search the full text of articles, as well as establish HTML links to them, without having to seek the consent of the author or publisher.
The right to use content without consent does not release the users from the obligation to give the credit to the journal and its content in a manner described under CC BY.